Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common stock, par value $0.001 per share (the "Common Stock")
-
Shares outstanding
-
138,764,349
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
24,329,456
-
Shares change
-
+3,921,745
-
Total reported value, excl. options
-
$45,009,540
-
Value change
-
+$7,661,442
-
Put/Call ratio
-
171%
-
Number of buys
-
32
-
Number of sells
-
35
-
Price
-
$1.85
Institutional Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) as of Q1 2017
As of 31 Mar 2017 ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) had 102 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 24,329,456 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, OppenheimerFunds, Inc., QVT Financial LP, PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C., STATE STREET CORP, NORTHERN TRUST CORP, PERCEPTIVE ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, and MILLENNIUM MANAGEMENT LLC.
This table shows 102 institutional shareholders of the security as of 31 Mar 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.